Neutrophil-to-Lymphocyte Ratio, a Novel Inflammatory Marker, as a Predictor of Bipolar Type in Depressed Patients: A Quest for Biological Markers
Open accessThe DOI matches its Crossref record; 77 of the 79 references it cites were found in a registry or an index; 12 of the 30 sources its claims cite were checked for support.
Abstract
(1) Background: Recent research suggests inflammation as a factor involved in the pathophysiology of mood disorders. Neutrophil-to-lymphocyte (NLR), monocyte-to-lymphocyte (MLR), platelet-to-lymphocyte (PLR), and systemic immune-inflammatory (SII) index ratios have been studied as peripheral markers of inflammation in bipolar and major depressive disorders. The purpose of this study is to comparatively analyze these inflammatory ratios among manic episodes of bipolar disorder, bipolar depression and unipolar depression. (2) Methods: 182 patients were retrospectively included in the study and divided into three groups: 65 manic patients, 34 patients with bipolar depression, and 83 unipolar depressive patients. White blood cells, neutrophils, monocytes, lymphocytes, and platelets were retrieved from the patients’ database. NLR, MLR, PLR, and SII index were calculated using these parameters. (3) Results: Patients with manic episodes had elevated NLR (p < 0.001), MLR (p < 0.01), PLR (p < 0.05), and SII index (p < 0.001) compared to unipolar depression and increased NLR (p < 0.05) and SII index (p < 0.05) when compared to bipolar depression. NLR (p < 0.01) and SII index (p < 0.05) were higher in the bipolar depression than unipolar depression. NLR is an independent predictor of the bipolar type of depression in depressive patients. (4) Conclusions: The results confirm the role of inflammation in the pathophysiology of mood disorders and suggest the ability of NLR as a marker for the differentiation of bipolar from unipolar depression.
Overview
CoChat Summary
TL;DR
In a retrospective inpatient sample, patients with bipolar mania had higher inflammatory ratios (NLR, MLR, PLR, SII) than unipolar depressed patients, and NLR and SII were also higher in bipolar depression than unipolar depression. NLR independently predicted bipolar rather than unipolar depression among depressed patients.
Key findings
- Manic patients had higher NLR (2.43 ± 0.95) than bipolar depressed (2.10 ± 0.96, p < 0.05) and unipolar depressed patients (1.55 ± 0.79, p < 0.001); bipolar depression had higher NLR than unipolar depression (p < 0.01).
- SII index was higher in mania (648.21 ± 295.79) than bipolar depression (549.40 ± 335.78, p < 0.05) and unipolar depression (415.13 ± 251.45, p < 0.001); bipolar depression had higher SII than unipolar depression (p < 0.05).
- PLR and MLR were higher in mania than unipolar depression: PLR 129.21 ± 50.19 vs. 113.5 ± 39.47 (p < 0.05); MLR 0.30 ± 0.11 vs. 0.25 ± 0.07 (p < 0.01).
- In binary logistic regression, NLR was an independent predictor of bipolar depression after adjustment (Model 3 OR = 5.311, p = 0.03); SII was not statistically associated in that model (OR = 0.997, p = 0.269).
Methods
- Retrospective, cross-sectional study of adult psychiatric inpatients admitted March 2020–January 2021 to “Prof. Dr. Alexandru Obregia” Clinical Hospital of Psychiatry, Bucharest, Romania; diagnoses based on ICD-10 criteria.
- N = 182 patients: 65 (35.71%) BD manic, 35 (19.23%) BD with depression in Results (abstract states 34 bipolar depression), and 83 (45.6%) MDD; inclusion age 18–65 and BD current manic/depressive episode (F31.1–F31.5) or MDD (F32.2, F32.3, F33.2, F33.3), with exclusions for other psychiatric comorbidities, inflammatory/medical conditions, BMI > 30 kg/m², heavy smoking, pregnancy, and recent anti-inflammatory/immunosuppressive/antibiotic treatment.
- Blood samples taken fasting in the morning (7:00–9:00 a.m.) within the first three days of hospitalization; NLR, MLR, PLR, and SII index calculated from white blood cells, neutrophils, monocytes, lymphocytes, and platelets; comparisons used parametric/nonparametric tests and binary logistic regression.
Limitations
- Stated: retrospective design prevented structured clinical interview; symptom severity was not evaluated; no euthymic or healthy subjects were included, so no causal modelling is possible; other factors such as lifestyle habits, menstrual cycle, and psychotropic treatment were not assessed despite adjustment for BMI, smoking, age, gender, glycemia, cholesterol, and triglycerides.
- Evident from the text: single-center inpatient sample; all included patients were under psychiatric pharmacological treatment at blood sampling; the reported number of bipolar depressed patients differs between the abstract (34) and Results (35).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
8 Valid · 1 Not valid · 3 Not checked · 30 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Numerous studies have established NLR and PLR as biomarkers for the manic phase of bipolar disorder [29,30,31,32,33,34,35].”
§ Neutrophil-to-Lymphocyte Ratio, a Novel Inflammatory Marker, as a Predictor of Bipolar Type in Depressed Patients: A Quest for Biological Markers > 1. Introduction
What the sources say
- Partly supportedcites [29] Mert D.G. Terzi H. Mean platelet volume in bipolar disorder: The search for an ideal biomarker Neuropsychiatr. Dis. Treat. 2016 12 2057 2062 10.2147/NDT.S112374 27578978 PMC4998027 sourceExperimental — accuracy not yet measured
The Discussion reports elevated NLR and PLR during manic episodes in patients with bipolar disorder. The Conclusion says they may be useful for detecting inflammatory activation, but does not establish them as biomarkers for the manic phase; it also does not substantiate the claim that numerous studies have established that use. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [30] Özdin S. Sarisoy G. Böke Ö. A Comparison of The Neutrophil-Lymphocyte, Platelet-Lymphocyte and Monocyte-Lymphocyte Ratios in Schizophrenia And Bipolar Disorder Patients—A Retrospective File Review Nord. J. Psychiatry 2017 71 509 512 10.1080/08039488.2017.1340517 28644753 source
- Not checked — no full text of the sourcecites [31] Özdin S. Usta M.B. A comparison of inflammatory markers in manic and euthymic states of bipolar disorder Nord. J. Psychiatry 2021 75 124 129 10.1080/08039488.2020.1807048 32804583 source
- Not checked — no full text of the sourcecites [32] Mayda H. Ahsen A. Bagcioglu E. Ozturk A. Bahceci B. Soyucok E. Baspinar E. Ulu M. Effect of Increased Neutro-phil-To-Lymphocyte Ratio (NLR) And Decreased Mean Platelet Volume (MPV) Values on Inflammation in Acute Mania Noro Psikiyatr. Ars. 2016 53 317 320 10.5152/npa.2016.10272 28360805 PMC5353037 source
- Not checked — no full text of the sourcecites [33] Kalelioglu T. Akkus M. Karamustafalioglu N. Genc A. Genc E.S. Cansiz A. Emul M. Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder Psychiatry Res. 2015 228 925 927 10.1016/j.psychres.2015.05.110 26154814 source
- Not checked — no full text of the sourcecites [34] Inanli I. Aydin M. Çaliskan A.M. Eren I. Neutrophil/lymphocyte ratio, monocyte/lymphocyte ratio, and mean platelet volume as systemic inflammatory markers in different states of bipolar disorder Nord. J. Psychiatry 2019 73 372 379 10.1080/08039488.2019.1640789 31304832 source
- Disputedcites [35] Ayhan M.G. Cicek I.E. Inanli I. Caliskan A.M. Ercan S.K. Eren I. Neutrophil/lymphocyte and platelet/lymphocyte ratios in all mood states of bipolar disorder Psychiatry Clin. Psychopharmacol. 2017 27 278 282 10.1080/24750573.2017.1338822 sourceExperimental — accuracy not yet measured
Our copy directly contradicts the PLR half of the claim: the Results (p. 3) and the Discussion summary (p. 3) state there was NO significant difference in PLR between the manic (p = .184), depressed (p = .638) or euthymic (p = .257) groups and controls, and the Abstract reports the same. Nor does the paper support 'biomarker for the manic phase' specifically: its Conclusion (Discussion, p. 4) says NLR is higher in manic, euthymic AND depressed patients and 'may be a trait inflammatory marker of BD independent of different episodes', with further longitudinal studies needed. Only the NLR-elevation-in-mania element (NLR 2.23 +/- 1.14 vs 1.52 +/- 0.47, p = .000) is consistent with the claim, and even that is framed as a hedged possible marker, not an established one. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Data from several meta-analyses outlines that patients suffering MDD or BD have increased different pro-inflammatory cytokines levels as compared with healthy controls [47,48,49,50].”
§ Neutrophil-to-Lymphocyte Ratio, a Novel Inflammatory Marker, as a Predictor of Bipolar Type in Depressed Patients: A Quest for Biological Markers > 4. Discussion
What the sources say
- Partly supportedcites [47] Zou W. Feng R. Yang Y. Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression PLoS ONE 2018 13 e0197267 10.1371/journal.pone.0197267 29856741 PMC5983476 sourceExperimental — accuracy not yet measured
The Discussion (page not supplied) reports higher IL-1β and TNF-α in antidepressant drug-naïve patients with MDD than in healthy controls. It does not report findings for bipolar disorder, and this paper is an original study rather than a meta-analysis. It also found lower IL-8 and no difference in IL-6, so the increase applies to specific pro-inflammatory cytokines, not all those measured. (LLM, conf=0.90)
- Partly supportedcites [48] Osimo E. Pillinger T. Rodriguez I. Khandaker G. Pariante C. Howes O. Inflammatory Markers in Depression: A Meta-Analysis of Mean Differences and Variability in 5166 Patients And 5083 Controls Brain Behav. Immun. 2020 87 901 909 10.1016/j.bbi.2020.02.010 32113908 PMC7327519 sourceExperimental — accuracy not yet measured
The Discussion reports increased TNFα, IL-6 and IL-12 during depressive episodes compared with controls, supporting the claim for depression. The Methods describe a comparison of patients with depression and healthy controls; our copy does not report a corresponding finding for bipolar disorder (BD). (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [49] Dowlati Y. Herrmann N. Swardfager W. Liu H. Sham L. Reim E.K. Lanctôt K.L. A Meta-Analysis of Cytokines in Major Depression Biol. Psychiatry 2010 67 446 457 10.1016/j.biopsych.2009.09.033 20015486 source
- Not checked — no full text of the sourcecites [50] Munkholm K. Vinberg M. Kessing L.V. Cytokines in bipolar disorder: A systematic review and meta-analysis J. Affect. Disord. 2013 144 16 27 10.1016/j.jad.2012.06.010 22749156 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Also, treatment between these illnesses differs substantially and prescription of antidepressants to bipolar patients is controversial and could worsen the clinical picture [70].”
§ Neutrophil-to-Lymphocyte Ratio, a Novel Inflammatory Marker, as a Predictor of Bipolar Type in Depressed Patients: A Quest for Biological Markers > 4. Discussion
What the sources say
- Supportedcites [70] Gitlin M.J. Antidepressants in bipolar depression: An enduring controversy Int. J. Bipolar Disord. 2018 6 25 10.1186/s40345-018-0133-9 30506151 PMC6269438 source
In “Antidepressants in bipolar depression: conceptual concerns” (page not provided), the paper contrasts antidepressants for unipolar depression with mood stabilizers for bipolar depression and identifies additional concerns when antidepressants are used in bipolar depression. This supports the attributed difference in treatment; the Background section also describes their use in bipolar depression as controversial. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Moreover, bipolar patients spend the majority of their symptomatic periods of time in the depressive phase and only 20% of bipolar patients in a depressive episode are diagnosed correctly within the first year of searching for treatment.”
§ Neutrophil-to-Lymphocyte Ratio, a Novel Inflammatory Marker, as a Predictor of Bipolar Type in Depressed Patients: A Quest for Biological Markers > 4. Discussion
What the sources say
- Partly supportedcites [1] Hirschfeld R. Differential diagnosis of bipolar disorder and major depressive disorder J. Affect. Disord. 2014 169 S12 S16 10.1016/S0165-0327(14)70004-7 25533909 sourceExperimental — accuracy not yet measured
The Introduction reports that bipolar patients spend most of their symptomatic time with depressive symptoms. It also describes frequent missed diagnoses among depressed patients, but does not report that only 20% are correctly diagnosed within the first year of seeking treatment; its 21% figure instead concerns patients treated for depression who screened positive for bipolar disorder. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [4] Grande I. Berk M. Birmaher B. Vieta E. Bipolar Disorder Lancet 2016 387 1561 1572 10.1016/S0140-6736(15)00241-X 26388529 source
- Not checked — no full text of the sourcecites [69] Bowden C.L. A different depression: Clinical distinctions between bipolar and unipolar depression J. Affect. Disord. 2005 84 117 125 10.1016/S0165-0327(03)00194-0 15708408 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Therefore, distinguishing bipolar from unipolar depression remains a clinical challenge [1].”
§ Neutrophil-to-Lymphocyte Ratio, a Novel Inflammatory Marker, as a Predictor of Bipolar Type in Depressed Patients: A Quest for Biological Markers > 4. Discussion
What the sources say
- Supportedcites [1] Hirschfeld R. Differential diagnosis of bipolar disorder and major depressive disorder J. Affect. Disord. 2014 169 S12 S16 10.1016/S0165-0327(14)70004-7 25533909 source
The Introduction says depressive episodes in bipolar disorder may look like unipolar depression and that bipolar patients may be misdiagnosed without appropriate screening. The Conclusion explicitly calls distinguishing bipolar from unipolar depression a diagnostic challenge. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
27 more claims · 1 with their cited sources checked
Create a free account to see all 42 claims and every source verdict.
- Probably not a substantial claim. 7
- It may state two separate claims as one. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although a few studies found significantly higher NLR or MLR values in bipolar depression than in unipolar depression, most studies observed no significant difference, which is consistent with previous findings.20,21”
From Association Between Mood Disorder Severity, Treatment Response and Systemic Inflammatory Markers: Exploring the Role of NLR, PLR, MLR, and SII (2024) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The association between leukocyte subtypes and affective disorders has been demonstrated in previous studies40,41.”
From Optimizing multi-domain hematologic biomarkers and clinical features for the differential diagnosis of unipolar depression and bipolar depression (2023) · doi:10.1038/s44184-023-00024-z · cites this paper as [41]
The cited source says what the claim attributes to it.
In the citing paper
“Similar results are presented in previous studies where SII index was higher in BD patients suffering from a depression episode than in patients with unipolar depression [28]”
The cited source says what the claim attributes to it.
In the citing paper
“supporting the evidence that mania is associated with higher levels of inflammation than bipolar depression.”
From Association Between Mood Disorder Severity, Treatment Response and Systemic Inflammatory Markers: Exploring the Role of NLR, PLR, MLR, and SII (2024) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“A study published in the literature found that the SII index is significantly higher in the BAD-M group than in the MDD and BAD-D groups.21”
From Association Between Mood Disorder Severity, Treatment Response and Systemic Inflammatory Markers: Exploring the Role of NLR, PLR, MLR, and SII (2024) · cites this paper as [21]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Neutrophil-to-Lymphocyte Ratio, a Novel Inflammatory Marker, as a Predictor of Bipolar Type in Depressed Patients: A Quest for Biological Markers > Abstract
“65 manic patients, 34 patients with bipolar depression, and 83 unipolar depressive patients.”
§ Neutrophil-to-Lymphocyte Ratio, a Novel Inflammatory Marker, as a Predictor of Bipolar Type in Depressed Patients: A Quest for Biological Markers > 3. Results
“65 (35.71%) BD manic patients, 35 (19.23%) BD patients with depression, and 83 (45.6%) MDD patients.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Neutrophil-to-Lymphocyte Ratio, a Novel Inflammatory Marker, as a Predictor of Bipolar Type in Depressed Patients: A Quest for Biological Markers > 5. Conclusions
“The results presented herein demonstrated that the inflammatory activation, viewed through NLR, MLR, PLR, and SII index, was higher during the manic phase of the bipolar disorder in comparison with the depressive phase of BD or unipolar depression.”
§ Neutrophil-to-Lymphocyte Ratio, a Novel Inflammatory Marker, as a Predictor of Bipolar Type in Depressed Patients: A Quest for Biological Markers > 3. Results
“Both PLR and MLR were higher in patients with mania episodes than patients with unipolar depression (129.21 ± 50.19 vs. 113.5 ± 39.47, p < 0.05), (0.30 ± 0.11 vs. 0.25 ± 0.07, p < 0.01). No other significant differences were found regarding PLR or MLR (Table 2 and Table 3, Figure 1).”
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
Monocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Grande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Rosales, C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00113 · Cited by 1,334
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Osimo, E. F., Pillinger, T., Rodriguez, I. M., Khandaker, G. M., Pariante, C. M., & Howes, O. D. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.02.010 · Cited by 937
Vieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.8 · Cited by 891
The neurobiology of depression: An integrated view
Dean, J., & Keshavan, M. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.01.025 · Cited by 765
Imtiaz, F., Shafique, K., Mirza, S., Ayoob, Z., Vart, P., & Rao, S. (2012) · International Archives of Medicine · doi:10.1186/1755-7682-5-2 · Cited by 645
Alonso, J., Petukhova, M., Vilagut, G., Chatterji, S., Heeringa, S., Üstün, T. B., Alhamzawi, A. O., Viana, M. C., Angermeyer, M., Bromet, E., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.101 · Cited by 482
Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis
Yang, R., Chang, Q., Meng, X., Gao, N., & Wang, W. (2018) · Journal of Cancer · doi:10.7150/jca.25691 · Cited by 441
Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019
Zhu, Z., Cai, T., Fan, L., Lou, K., Hua, X., Huang, Z., & Gao, G. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.04.041 · Cited by 435 · cited 1×
“An increased count of neutrophils reflects the intensity of inflammatory response and a decreased count of lymphocytes represents the immune system impairment [23].”
BackgroundKöhler‐Forsberg, O., N. Lydholm, C., Hjorthøj, C., Nordentoft, M., Mors, O., & Benros, M. E. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13016 · Cited by 432
Can bipolar disorder be viewed as a multi-system inflammatory disease?
Leboyer, M., Soreca, I., Scott, J., Frye, M., Henry, C., Tamouza, R., & Kupfer, D. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.049 · Cited by 417
Rheumatoid arthritis and depression: an inflammatory perspective
Nerurkar, L., Siebert, S., McInnes, I. B., & Cavanagh, J. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30255-4 · Cited by 413
Maes, M. H. J., Kubera, M., Obuchowiczwa, E., Goehler, L. E., & Brzeszcz, J. (2011) · PubMed · Cited by 374
Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis
Mazza, M. G., Lucchi, S., Tringali, A. G. M., Rossetti, A., Botti, E. R., & Clerici, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.03.012 · Cited by 326 · cited 9×
“Mazza et al. (2018) were the first to compare these hemogram-derived inflammatory ratios between different phases of BD (i.e., mania and depression) [62].”
BackgroundResultInfluentialRosenblat, J., & McIntyre, R. (2017) · Brain Sciences · doi:10.3390/brainsci7110144 · Cited by 258
Cytokines in bipolar disorder: A systematic review and meta-analysis
Munkholm, K., Vinberg, M., & Vedel Kessing, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.010 · Cited by 256
Fernandes, B. S., Steiner, J., Molendijk, M. L., Dodd, S., Nardin, P., Gonçalves, C.-A., Jacka, F., Köhler, C. A., Karmakar, C., Carvalho, A. F., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30370-4 · Cited by 247 · cited 1×
“These findings are in accordance with results from recent meta-analyses that reported the high levels of other inflammatory markers, such as CRP or high sensitivity-CRP, IL-6, soluble tumor necrosis factor receptor (sTNFR) 1 during the manic shift of BD compared to those with bipolar depression [64,65].”
ResultAssociation between Systemic Immune-Inflammation Index and Diabetic Depression
Wang, J., Zhou, D., Dai, Z., & Li, X. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s285000 · Cited by 238
Bai, S., Guo, W., Feng, Y., Deng, H., Li, G., Nie, H., Guo, G., Yu, H., Ma, Y., Wang, J., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-320912 · Cited by 235 · cited 1×
“, celecoxib, statins, and omega-3 fatty acids) in monotherapy, or as an add-on to a selective serotonin reuptake inhibitor, were reported to reduce depression in patients with MDD compared with monotherapy with a selective serotonin reuptake inhibitor [51,52].”
BackgroundDifferential diagnosis of bipolar disorder and major depressive disorder
Hirschfeld, R. M. (2014) · Journal of Affective Disorders · doi:10.1016/s0165-0327(14)70004-7 · Cited by 234
Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis
Li, B., Zhou, P., Liu, Y., Wei, H., Yang, X., Chen, T., & Xiao, J. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.04.023 · Cited by 230
Zou, W., Feng, R., & Yang, Y. (2018) · PLOS ONE · doi:10.1371/journal.pone.0197267 · Cited by 224
A different depression: clinical distinctions between bipolar and unipolar depression
Bowden, C. L. (2005) · Journal of Affective Disorders · doi:10.1016/s0165-0327(03)00194-0 · Cited by 207 · cited 1×
“An important aspect is that bipolar depression is frequently misdiagnosed with MDD [1,4,69].”
BackgroundInterferon alpha (IFNα) and psychiatric syndromes
Schaefer, M., Engelbrechta, M. A., Gut, O., Fiebich, B. L., Bauer, J., Schmidt, F., Grunze, H., & Lieb, K. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00324-4 · Cited by 202
Rosenblat, J. D., Kakar, R., Berk, M., Kessing, L. V., Vinberg, M., Baune, B. T., Mansur, R. B., Brietzke, E., Goldstein, B. I., & McIntyre, R. S. (2016) · Bipolar Disorders · doi:10.1111/bdi.12373 · Cited by 199 · cited 1×
“Moreover, N-acetylcysteine had an anti-depressant effect in bipolar depression as concluded by a meta-analysis conducted by Rosenblat et al. (2016) [53].”
BackgroundRowland, T., Perry, B. I., Upthegrove, R., Barnes, N., Chatterjee, J., Gallacher, D., & Marwaha, S. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2018.144 · Cited by 196
Bipolar Disorder and Inflammation
Rosenblat, J. D., & McIntyre, R. S. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.09.006 · Cited by 186
Dionisie, V., Filip, G. A., Manea, M. C., Manea, M., & Riga, S. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00777-5 · Cited by 181
Self-citationAtli, A., Demir, S., Bulut, M., Okan İbiloğlu, A., Güneş, M., Kaya, M., Demirpençe, Ö., & Sır, A. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s89470 · Cited by 156
Özdin, S., Sarisoy, G., & Böke, Ö. (2017) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2017.1340517 · Cited by 148
Aydin Sunbul, E., Sunbul, M., Yanartas, O., Cengiz, F., Bozbay, M., Sari, I., & Gulec, H. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.1.121 · Cited by 145
Bai, Y.-M., Su, T.-P., Li, C.-T., Tsai, S.-J., Chen, M.-H., Tu, P.-C., & Chiou, W.-F. (2015) · Bipolar Disorders · doi:10.1111/bdi.12259 · Cited by 135
Erdoğan, M., Erdöl, M. A., Öztürk, S., & Durmaz, T. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2020-0274 · Cited by 128
Ramírez, K., Trías, J. F., & Sheridan, J. F. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_25 · Cited by 126
Fernandes, B. S., Gama, C. S., Kauer-Sant’Anna, M., Lobato, M. I., Belmonte-de-Abreu, P., & Kapczinski, F. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.04.010 · Cited by 124
Differential contribution of microglia and monocytes in neurodegenerative diseases
Baufeld, C., O’Loughlin, E., Calcagno, N., Madore, C., & Butovsky, O. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-017-1795-7 · Cited by 123
Antidepressants in bipolar depression: An enduring controversy
Gitlin, M. J. (2018) · International Journal of Bipolar Disorders · doi:10.1186/s40345-018-0133-9 · Cited by 116
Jacomb, I., Stanton, C., Vasudevan, R., Powell, H., O'Donnell, M., Lenroot, R., Bruggemann, J., Balzan, R., Galletly, C., Liu, D., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02230 · Cited by 110
Kulaksizoglu, B., & Kulaksizoglu, S. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s110484 · Cited by 107
Kayhan, F., Gündüz, Ş., Ersoy, S. A., Kandeğer, A., & Annagür, B. B. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2016.11.016 · Cited by 106
Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder
Kalelioglu, T., Akkus, M., Karamustafalioglu, N., Genc, A., Genc, E. S., Cansiz, A., & Emul, M. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.110 · Cited by 105
Role of platelets in neuroinflammation: a wide-angle perspective
Horstman, L. L., Jy, W., Ahn, Y. S., Zivadinov, R., Maghzi, A. H., Etemadifar, M., Steven Alexander, J., & Minagar, A. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-10 · Cited by 102
Differences in the immune-inflammatory profiles of unipolar and bipolar depression
Brunoni, A. R., Supasitthumrong, T., Teixeira, A. L., Vieira, E. L., Gattaz, W. F., Benseñor, I. M., Lotufo, P. A., Lafer, B., Berk, M., Carvalho, A. F., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.10.037 · Cited by 94 · cited 2×
“More precisely, MDD had increased IL-1β, tumor necrosis factor α (TNF α), sTNFR 1, IL-12 and IL-10 while BD depression was characterised by an increase in IL-6, sTNFR 2, IL-18, IL-33, ST2, and KLOTHO [72].”
BackgroundFusar-Poli, L., Natale, A., Amerio, A., Cimpoesu, P., Grimaldi Filioli, P., Aguglia, E., Amore, M., Serafini, G., & Aguglia, A. (2021) · Brain Sciences · doi:10.3390/brainsci11010058 · Cited by 93
Ivković, M., Pantović-Stefanović, M., Dunjić-Kostić, B., Jurišić, V., Lačković, M., Totić-Poznanović, S., Jovanović, A. A., & Damjanović, A. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.01.005 · Cited by 89 · cited 2×
“They are nonspecific inflammatory cells with phagocytic and apoptotic roles mediated by releasing the cytokines and other inflammatory molecules [10,11].”
BackgroundMazza, M. G., Tringali, A. G. M., Rossetti, A., Botti, R. E., & Clerici, M. (2019) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2019.02.003 · Cited by 89 · cited 2×
“(2018) compared the ratios between BD mania and MDD and reported higher NLR and MLR in manic versus MDD patients [62].”
BackgroundTargeting the immune system in the treatment of bipolar disorder
Rosenblat, J. D. (2019) · Psychopharmacology · doi:10.1007/s00213-019-5175-x · Cited by 82
Dietrich-Muszalska, A., & Wachowicz, B. (2017) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2016.1155748 · Cited by 78 · cited 1×
“Platelets have been suggested to be involved in neuroinflammation and they have been used as peripheral models of receptor-mediated signal transduction in the central nervous system [12,13].”
MethodBai, Y.-M., Chen, M.-H., Hsu, J.-W., Huang, K.-L., Tu, P.-C., Chang, W.-C., Su, T.-P., Li, C. T., Lin, W.-C., & Tsai, S.-J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1724-9 · Cited by 78
Wang, J.-R., Chen, Z., Yang, K., Yang, H.-J., Tao, W.-Y., Li, Y.-P., Jiang, Z.-J., Bai, C.-F., Yin, Y.-C., Duan, J.-M., et al. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00562-y · Cited by 74
Ruta, V. M., Man, A. M., Alexescu, T. G., Motoc, N. S., Tarmure, S., Ungur, R. A., Todea, D. A., Coste, S. C., Valean, D., & Pop, M. C. (2020) · Medicina · doi:10.3390/medicina56080381 · Cited by 70
Inanli, I., Aydin, M., Çaliskan, A. M., & Eren, I. (2019) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2019.1640789 · Cited by 69
Differential biomarker signatures in unipolar and bipolar depression: A machine learning approach
Wollenhaupt-Aguiar, B., Librenza-Garcia, D., Bristot, G., Przybylski, L., Stertz, L., Kubiachi Burque, R., Ceresér, K. M., Spanemberg, L., Caldieraro, M. A., Frey, B. N., et al. (2020) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419888027 · Cited by 68
Mao, R., Zhang, C., Chen, J., Zhao, G., Zhou, R., Wang, F., Xu, J., Yang, T., Su, Y., Huang, J., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.115 · Cited by 68
Mean platelet volume in bipolar disorder:The search for an ideal biomarker
Mert, D. G., & Terzi, H. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s112374 · Cited by 67
Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severity.
Gao, S., Huang, L., Dai, R.-J., Chen, D., Hu, W., & Shan, Y. (2015) · PubMed · Cited by 66
Minogue, A. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.02.008 · Cited by 65
C-Reactive Protein: A Differential Biomarker For Major Depressive Disorder and Bipolar II Disorder
Chang, H. H., Wang, T.-Y., Lee, I. H., Lee, S.-Y., Chen, K. C., Huang, S.-Y., Yang, Y. K., Lu, R.-B., & Chen, P. S. (2017) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2016.1155746 · Cited by 61 · cited 1×
“6 ng/mL) have been suggested to differentiate between bipolar and unipolar depression [73].”
BackgroundZhou, L., Ma, X., & Wang, W. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s216389 · Cited by 58 · cited 3×
“(2020) reported that MDD patients have an increased SII index compared with healthy controls [45].”
BackgroundInfluentialTakahashi, Y., Yu, Z., Sakai, M., & Tomita, H. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00144 · Cited by 56
Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
Benedetti, F., Mazza, M., Cavalli, G., Ciceri, F., Dagna, L., & Rovere-Querini, P. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09966-z · Cited by 55
Zulfic, Z., Weickert, C. S., Weickert, T. W., Liu, D., Myles, N., & Galletly, C. (2020) · Australasian Psychiatry · doi:10.1177/1039856220908172 · Cited by 54
Chen, M., Chang, W.-C., Hsu, J.-W., Huang, K., Tu, P., Su, T., Li, C., Lin, W.-C., & Bai, Y. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.106 · Cited by 49
Jung, J.-Y., Lee, E., Suh, C., & Kim, H.-A. (2019) · Journal of clinical laboratory analysis (Print) · doi:10.1002/jcla.23000 · Cited by 45
Arabska, J., Łucka, A., Magierski, R., Sobów, T., & Wysokiński, A. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.02.043 · Cited by 42
Mayda, H., Ahsen, A., Bagcioglu, E., Ozturk, A., Bahceci, B., Soyucok, E., Baspinar, E., & Ulu, M. S. (2016) · Noro Psikiyatri Arsivi · doi:10.5152/npa.2016.10272 · Cited by 33
A comparison of inflammatory markers in manic and euthymic states of bipolar disorder
Özdin, S., & Usta, M. B. (2021) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2020.1807048 · Cited by 30 · cited 1×
“Regarding MLR, increased levels were observed in the manic phase of bipolar illness [30,31,34].”
BackgroundNeutrophil/lymphocyte and platelet/lymphocyte ratios in all mood states of bipolar disorder
Giynas Ayhan, M., Cicek, I. E., Inanli, I., Caliskan, A. M., Kirci Ercan, S., & Eren, I. (2017) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2017.1338822 · Cited by 26
Islas-Vázquez, L., Aguilar‐Cázares, D., Galicia-Velasco, M., Rumbo‐Nava, U., Meneses-Flores, M., Luna-Rivero, C., & López-González, J. S. (2020) · Biology · doi:10.3390/biology9110376 · Cited by 26
Fusar-Poli, L., Surace, T., Vanella, A., Meo, V., Patania, F., Furnari, R., Signorelli, M. S., & Aguglia, E. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.039 · Cited by 24
Cited by
Xiao, S., Wang, Z., Zuo, R., Zhou, Y., Yang, Y., Chen, T., & Liu, N. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s402227 · Cited by 101
Zhou, L., Xiong, J., Chai, Y.-Q., Huang, L., Tang, Z.-Y., Zhang, X., Liu, B., & Zhang, J.-T. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.933704 · Cited by 131
Liu, X., Guan, G., Cui, X., Liu, Y., Liu, Y., & Luo, F. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s343110 · Cited by 105
Xiao, S., Wang, X., Zhang, G., Tong, M., Chen, J., Zhou, Y., Ji, Q., & Liu, N. (2023) · Mediators of Inflammation · doi:10.1155/2023/1966680 · Cited by 90
Bioque, M., Matias-Martins, A. C., Llorca-Bofí, V., Mezquida, G., Cuesta, M. J., Vieta, E., Amoretti, S., Lobo, A., González-Pinto, A. M., Moreno, C., et al. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac089 · Cited by 67
Metadata
- Authors
- Dionisie, V., Filip, G. A., Manea, M. C., Movileanu, R. C., Moisa, E., Manea, M., Riga, S., & Ciobanu, A. M.
- Affiliations
- Carol Davila University of Medicine and Pharmacy (RO)
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
- Spitalul Clinic de Psihiatrie Alexandru Obregia (RO)
- Department of Orthopaedics, Anaesthesia and Intensive Care Medicine, ‘Carol Davila’ University of Medicine and Pharmacy, 020021 Bucharest, Romania
- Corresponding author
- Dionisie, Vlad
- Manea, Mihnea Costin
- ORCID
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2021-04-29
- Volume
- 10
- Issue
- 9
- Pages
- 1924
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC8125288
- OpenAlex
- W3158490350
- Cited by
- 82
- References
- 79
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 20 · 2023: 18 · 2022: 11 · 2021: 1
- FWCI
- 8.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- neutrophil-to-lymphocyte ratio, inflammatory markers, bipolar depression, major depressive disorder, manic episodes, bipolar disorder, systemic immune-inflammation index, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, mood disorders, biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.